Elsevier Announces Updates to Two Key Virology Titles, Publication of Seven Additional Virology and Microbiology Books

Fifth Editions of "Fenner and White's Medical Virology" and "Fenner's Veterinary Virology" Provide Revised and Expanded Resources for Students, Researchers and Educators


CAMBRIDGE, MA--(Marketwired - December 06, 2016) - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of the latest editions of Fenner and White's Medical Virology by Drs. Christopher Burrell, Colin Howard and Frederick Murphy, and Fenner's Veterinary Virology by Drs. N. James MacLachlan and Edward Dubovi. These thoroughly revised books provide comprehensive coverage of viruses in humans and animals for students, researchers, educators, practitioners and public health officials. Elsevier also announced that it has published seven additional titles on virology and microbiology.

Fenner and White's Medical Virology, Fifth Edition offers an integrated view of related sciences, from cell biology, to human social behavior to public health challenges. It features updated and expanded coverage of pathogenesis and immunity, and contains the latest laboratory diagnostic methods. This classic text includes insights into clinical features of human viral disease, vaccines, chemotherapy, epidemiology and control.

Learn more about laboratory diagnosis of virus diseases in this sample chapter.

Fenner's Veterinary Virology, Fifth Edition features coverage on viral agents, viral diseases of animals, and newly emerging viral zoonotic diseases. It is an excellent resource for researchers and students alike, presenting the fundamental principles of virology, virus structure, genome replication, and viral diseases, while also focusing on the topics' clinical aspects.

Read about antiviral immunity and virus vaccines in this sample chapter.

The nine new virology and microbiology titles are:

In order to meet content needs in virology and microbiology, Elsevier uses proprietary tools to identify the gaps in coverage of the topics. Editorial teams strategically fill those gaps with content written by key influencers in the field, giving students, faculty and researchers the content they need to answer challenging questions and improve outcomes. These new books, which will educate the next generation of virologists and microbiologists, and provide critical foundational content for information professionals, are key examples of how Elsevier is enabling science to drive innovation.

Note for Editors
E-book review copies of the new books are available to credentialed journalists upon request. Contact Jelena Baras at sciencereviewcopies@elsevier.com.

About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions -- among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey -- and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com

Image Available: http://www.marketwire.com/library/MwGo/2016/12/5/11G124217/Images/Fenner_s_Veterinary_Virology,_5e_cover-d0a4a86295c0b686945ce439ab473c1d.jpg
Image Available: http://www.marketwire.com/library/MwGo/2016/12/5/11G124217/Images/Fenner_and_White_s_Medical_Virology,_5e_cover-7b5932f91b4097508e9b6eb9a6291bee.jpg

Contact Information:

Media Contact
Pam Foote
Publicity Team, Science & Technology Books, Elsevier
footep@reedelsevier.com
+1-978-691-5572

Elsevier, books, virology, virus, veterinary, zoonotic, genome, animals Elsevier, books, virology, microbiology, cell biology, pathogenesis, immunity
Company ProfileElsevier, Inc.